Skip to main content
OpenTrials

Clinical trial condition

Recurrent Small-cell Lung Cancer (SCLC)

Explore clinical trials studying Recurrent Small-cell Lung Cancer (SCLC). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Small-cell Lung Cancer (SCLC) trial results

Completed

Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer

NCT00698516

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Cancer, Small Cell, +9 more
Locations
  • GSK Investigational Site Jonesboro, Arkansas, United States
  • GSK Investigational Site Gainesville, Florida, United States
  • GSK Investigational Site Naples, Florida, United States
  • GSK Investigational Site Athens, Georgia, United States
View all 16 locations
View Trial Details

Related conditions